June 10, 2025: EMA Finds Rybelsus Increases the Risk of Eye Strokes and Vision Loss After reviewing non-clinical studies, clinical trials, post-marketing surveillance, and medical literature, the European Medicines Agency (EMA) has determined that Rybelsus increases a persons risk of developing NAION
This information can support a more personalized conversation about whether GLP-1 agonist therapy, dual-receptor compounds, or alternative approaches align with your metabolic needs
Synergistic Mechanisms By integrating these two compounds, researchers can examine the co-agonist effect on the hypothalamus and hindbrain: Cagrilintide (5mg): An analog of the hormone amylin, researched for its role in satiation and slowing gastric emptying
Since its release in 2017, the wonder drug has garnered overwhelming demand as we know, less for treating diabetes than for its weight loss effects
Filed Under: Metabolic disease/endicrinology
We capture standardized photos to document tretinoin cream before and after changes and link them to decisions made within tretinoin vs hydroquinone frameworks
)
